UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 7, 2011 (October 4, 2011)
AdvanSource Biomaterials Corporation
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
000-28034
|
04-3186647
|
||
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
229 Andover Street, Wilmington, Massachusetts
|
01887
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
(978) 657-0075
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.07. Submission of Matters to a Vote of Security Holders
On October 4, 2011, AdvanSource Biomaterials Corporation (the “Company”) held its 2011 Annual Meeting of Stockholders (the “Meeting”). At the Meeting, there were 17,907,058 shares of common stock represented to vote either in person or by proxy, or 83.9% of the outstanding shares of common stock, which represented a quorum. As of the record date of August 5, 2011, there were 21,350,055 shares of common stock outstanding and entitled to vote at the Meeting. At the Meeting, the following proposals were voted upon and approved.
|
For
|
Withheld
|
Broker
Non-Votes
|
||||
|
Proposal 1. Election of Directors.
|
||||||
|
Mark R. Tauscher
|
4,170,682
|
322,473
|
13,413,903
|
|||
|
For
|
Against
|
Abstain
|
||||
|
Proposal 2. Ratify the selection of McGladrey & Pullen, LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2012.
|
16,731,262
|
1,125,964
|
49,832
|
|||
|
|
SIGNATURES
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ADVANSOURCE BIOMATERIALS CORPORATION
By: /s/ Michael F. Adams____
Michael F. Adams
President & CEO
Dated: October 7, 2011